Drug authorisation inthe EU
-
Plenary
in englischer Sprache
|
Dr. Marcus MÜLLNER
Chief Executive Officer and Partner, PERI Change GmbH, Vienna
| 1992 | MD, Medizinische Universität Wien |
| Junior House Officer, Evangelisches Krankenhaus, Wien; | |
| Compulsory military service Military Hospital, Österreichisches Bundesheer | |
| 1992-1993 | Research Fellow, Univ.-Klinik für Notfallmedizin, Wien |
| 1993-1999 | Specialist registrar, Univ.-Klinik für Notfallmedizin, Allgemeines Krankenhaus, Wien |
| 1998-1999 | Editorial registrar, British Medical Journal, London |
| 1999 | Habilitation, Universitäts Dozent für Innere Medizin, Universität Wien |
| 1999-2005 | Associate Editor, British Medical Journal, London |
| since 1999 | Associate Professor of Internal Medicine, Universität Wien, Allgemeines Krankenhaus, Wien |
| 2000 | Specialist in Internal Medicine |
| 2000-2004 | Consultant Internal Medicine, Univ.-Klinik für Notfallmedizin, Allgemeines Krankenhaus, Wien |
| 2001-2004 | Member of the Medical University of Vienna ethics committee |
| 2001-2005 | Statistical Editor, Cochrane Anaesthesia Review Group |
| 2002 | MSc. in Epidemiology, University College of London, London School of Hygiene and Tropical Medicine |
| 2003 | Subspecialty for Intensive Care |
| 2003-2004 | Statistician of the ethics committee of Wiener Krankenanstaltenverbund |
| 2004-2005 | National expert in secondment, European Medicines Agency (Sector for Scientific Advice and Orphan Drugs, London UK) |
| 2005-2013 | Head, Austrian Medicines and Medical Devices Agency, Austria |
